论文部分内容阅读
美《内科新闻》第12卷第20期(1979年)报道伦敦消息:奥斯陆鸟勒瓦医院阿内森(Harald Arnesen)医生在第7届国际血栓和止血会议上说,预防性施用肝素以减少急性心肌梗塞病人的深部静脉血栓的危险性,并不增加室性心律不齐的危险。以前的研究表明,肝素可活化脂蛋白脂酶,从而增加血浆游离脂肪酸的水平,增加室性心律不齐的危险性。不过,在二组经皮下注射肝素或华法令的病人中,室性心律不齐的发生率相似。病人
US Internal Medicine Vol.12, No.20 (1979) London News: Dr Harald Arnesen at the Sixth International Thrombosis and Hemostasis Conference in Oslo, Norway, said prophylactic administration of heparin to reduce The risk of deep venous thrombosis in patients with acute myocardial infarction does not increase the risk of ventricular arrhythmias. Previous studies have shown that heparin can activate lipoprotein lipase, thereby increasing the level of plasma free fatty acids and increase the risk of ventricular arrhythmia. However, the incidence of ventricular arrhythmias was similar in two groups of patients who were subcutaneously injected with heparin or warfarin. patient